The Payer Relations Director (PRD), is a remote, home based position and is responsible for the successful coverage and reimbursement as well as the overall management of coverage, coding, and reimbursement processes within an assigned region encompassing commercial insurance, MAC(s), Medicaid. Successful performance will include establishing favorable payer coverage, ensuring fair and consistent payment, and removing barriers in the overall reimbursement process. The position is also responsible for the coordination and execution of reimbursement support for KOL healthcare providers that are influencers within the assigned geography on payers, state societies to impact favorable coding, coverage and access. The PRD partners with the Glacoma Reimbursement Liaison Team and RL leadership team to deliver consultations with KOL physicians and institutional customers through specialized services to assist with reimbursement barriers. This position interacts with a variety of customers to include; medical directors, MAC medical policy staff, MAC case managers, CMS MAC medical directors and staff, state government health staffers, state society and advocacy groups, KOL physicians, hospital and ASC staff. They will serve as an expert in payer policies and provide support to facilitate appropriate coverage, payment, patient access and utilization of services to ensure their access to care. The PRD will promote collaboration with the Sales, Customer Relations, Reimbursement Liaisions, and Medical Affairs teams to achieve payer and provider strategic business goals along with build the relationships and foundation with key healthcare stakeholders to establish a foundation for coding, coverage and payment for future technologies. This candidate must be organized and detail-oriented. Demonstrated teamwork abilities with high emotional intelligence in managing multiple business initiatives and cross-functional relationships with key internal and external healthcare stakeholders will be a requirement to achieve their goals.
Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible.
Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.
